A new government notice aims to stop pharmaceutical companies from influencing doctors through vacations, gifts, and free educational materials. While the move targets unethical prescribing incentives, experts argue it’s unlikely to be effective without stronger enforcement and accountability mechanisms across the healthcare ecosystem.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
